Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: Attenuation in CuZn-superoxide dismutase transgenic mice

Brain Research

Volumn 714, Issue 1-2, 1996, Pages 95-103

  Hirata, Hiroshi ^a   Ladenheim, Bruce ^a   Carlson, Elaine ^b   Epstein, Charles ^b   Cadet, Jean Lud ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dopamine uptake site; Gender; Methamphetamine; Striatum; Superoxide dismutase; Superoxide radical; Transgenic mouse

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; TRANSGENIC MOUSE;

EID: 0029916294     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01502-7     Document Type: Article

References (43)

1. Baldwin, H.A., Colado, M.I., Murry, T.K., De Souza, R.J. and Green, A.R., Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine, Br. J. Pharmacol., 108 (1993) 590-596.
2. Beckman, J.S., The double-edged role of nitric oxide in brain and superoxide-mediated injury, J. Dev. Physiol., 15 (1991) 53-59.
3. Boja, J.W., Cadet, J.L., Kopajtic, T.A., Lever, J., Seltzman, H.H., Wyrick, C.D., Lewin, A.H., Abraham, P. and Carroll, F.I., Selective labeling of the dopamine transporter by the high affinity 3-(4-[125I]iodophenyl)tropane-2-carboxylic acid isopropyl ester, Mol. Pharmacol., 47 (1995) 779-786.
4. Cadet, J.L., A unifying hypothesis of movement and madness: involvement of free radicals in disorders of the isodendritic core, Med. Hypotheses, 27 (1988) 87-94.
5. Cadet, J.L., Ladenheim, B., Baum, I., Carlson, E. and Epstein, C., CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetaine (MDMA), Brain Res., 655 (1994) 259-262.
6. Cadet, J.L., Ladenheim, B., Hirata, H., Rothman, R.B., Ali, R,B., Carlson, E., Epstein, C. and Moran, T.H., Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide transgenic mice, Synapse, 21 (1995) 169-176.
7. Cadet, J.L., Sheng, P., Ali, S., Rothman, R., Carlson, E. and Epstein, C.J., Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice, J. Neurochem., 62 (1994) 380-383.
8. Cohen, G. and Heikkila, R.E., The generation of hydrogen peroxide, superoxide radical and hydroxyl radical by hydroxy-dopamine, dialuric acid, and related cytotoxic agents, J. Biol. Chem., 249 (1974) 2447-2452.
9. Coyle, J.T. and Puttfarcken, P., Oxidative stress, glutamate, and neurodegenerative disorders, Science, 262 (1993) 689-695.
10. Cubells, J.F., Rayport, S., Rajndron, G. and Sulzer, D., Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress, J. Neurosci., 14 (1994) 2260-2271.
11. Dawson, V.L., Dawson, T.M., Hartley, D.A., Uhl, G.R. and Snyder, S.H., Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures, J. Neurosci., 13 (1993) 2651-2661.
12. De Vito, M.J. and Wagner, G.C., Methamphetamine-induced neuronal damage: a possible role for free radicals, Neuropharmacology, 28 (1989) 1145-1150.
13. Eisch, A.J., Gaffney, M., Weihmuller, F.B., O'Dell, S.J. and Marshall, J.F., Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine, Brain Res., 598 (1992) 321-326.
14. Ellison, G., Ellison, M.S., Huberman, H.S. and Daniel, F., Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration, Science, 201 (1978) 276-278.
15. Elsworth, J.D., Deutch, A.Y., Redmond, D.E., Jr., Taylor, J.R., Sladek, J.R., Jr. and Roth, R.H., Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3.6-tetrahydropyridine-treated primates: biochemical changes in striatal regions, Neuroscience, 33 (1978) 323-331.
16. Epstein, C.J., Avraham, K.B., Lovett, M., Smith, S., Elroy-Stein, O., Rotman, G., Bry, C. and Groner, Y., Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome, Proc. Natl. Acad. Sci. USA, 84 (1987) 8044-8048.
17. Fridovich, I., Biological effects of the superoxide radical, Arch. Biochem. Biophys., 247 (1986) 1-11.
18. Gerfen, C.R., The neostriatal mosaic; compartmentalization of corticostriatal input and striatonigral output system, Nature, 311 (1984) 461-463.
19. Giovanni, A., Liang, L.P., Hastings, T.G. and Zigmond, M.J., Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine, J. Neurochem., 64 (1995) 1819-1825.
20. Hirata, H., Ladenheim, B., Rothman, R.B., Epstein, C. and Cadet, J.L., Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals, Brain Res., 677 (1995) 345-347.
21. Hotchkiss, A.J. and Gibb, J.W., Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain, J. Pharmacol. Exp. Ther., 214 (1980) 257-262.
22. Kish, S.J., Shannak, K. and Hornykiewicz, O., Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease, New Engl. J. Med., 318 (1988) 876-880.
23. Lafon-Cazal, M., Pietri, S., Culcasi, M. and Bockaert, J., NMDA-dependent superoxide production and neurotoxicity, Nature, 364 (1993) 535-537.
24. Marshall, J.F., O'Dell, J.Y. and Weihmuller, F.B., Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity, J. Neural Transm. Gen. Sect., 98 (1993) 241-254.
25. McDermott, J.L., Liu, B. and Dluzen, D.E., Sex differences and effects of estrogen on dopamine, DOPAC release from the striatum of male and female CD-1 mice, Exp. Neurol., 125 (1994) 306-311.
26. Mayeux, R, Denaro, J., Hemenegildo, N., Marder, K., Tang, M.X., Cote, L.J. and Stern, Y., A population-based investigation of Parkinson's disease with and without dementia, Arch. Neurol., 49 (1992) 492-497.
27. Nakayama, M., Koyama, T. and Yamashita, I., Long-lasting decreases in dopamine uptake sites following repeated administration of methamphetamine in the rat striatum, Brain Res., 601 (1992) 209-212.
28. Nash, J.F. and Yamamoto, B.K., Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine, Brain Res., 581 (1992) 237-243.
29. O'Callaghan, J.P. and Miller, D.E., Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse, J. Pharmacol. Exp. Ther., 270 (1994) 741-751.
30. O'Dell, S.J., Weihmller, J.F. and Marshall, J.F., Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists, J. Neurochem., 60 (1993) 792-799.
31. O'Dell, S.J., Weihmuller, F.B., Mcpherson, R.J. and Marshall, J.F., Excitotoxic striatal lesions protect against subsequent methamphetamine-induced dopamine depletions, J. Phamacol. Exp. Ther., 269 (1994) 1319-1325.
32. Pisa, M. and Schanz, J.A., Dissociable motor roles of the rat's striatum conform to somatotopic model, Behav. Neurosci., 102 (1998) 429-440.
33. Ricaurte, G.A., Schuster, C.R. and Seiden, L.S., Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: regional study, Brain Res., 193 (1980) 153-163.
34. Seiden, L.S. and Vosmer, G., Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine, Pharmacol. Biochem. Behav., 21 (1984) 29-31.
35. Sonsalla, P.K., Nicklas, W.J. and Heikkila, R.E., Role for excitatory amino acids in methamphetamine-induced dopaminergic toxicity, Science, 243 (1989) 398-400.
36. Sonsalla, P.K., Riordan, D.E. and Heikkila, R.E., Competitive and noncompetitive antagonists at N-methyl-D-asparate receptors protect against methamphetamine-induced dopaminergic damage in mice, J. Pharmacol. Exp. Ther., 256 (1994) 506-512.
37. Steranka, L.R. and Sanders-Bush, E., Long-term effects of continuous exposure to amphetamine in brain dopamine concentration and synaptosomal uptake in mice, Eur. J. Pharmacol., 65 (1980) 439-443.
38. Sulzer, D. and Rayport, S., Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action, Neuron, 5 (1990) 797-808.
39. Sulzer, D., Pothos, E., Sung, H.M., Maidment, N.T., Hoebel, B.G. and Rayport, S., Weak base model of amphetamine action, Ann. New York Acad. Sci., 654 (1992) 525-528.
40. Wagner, G.C., Carelli, R.M. and Jarvis, M.F., Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats, Res. Commun. Chem. Pathol. Pharmacol., 47 (1985) 221-228.
41. Wagner, G.C., Ricaurte, G.A., Seiden, L.S., Schuster, C.R., Miller, R.J. and Westley, J., Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine, Brain Res., 181 (1980) 151-160.
42. Wagner, G.C., Tekirian, T.L. and Choe, C.T., Sexual differences in sensitivity to methamphetamine toxicity, J. Neural Transm. Gen. Sect., 93 (1993) 67-70.
43. Yamada, S., Yokoo, H. and Nishi, S., Effects of N-ethylmaleimide on dopamine release in the rat striatum after repeated treatment with methamphetamine, Eur. J Pharmacol., 257 (1994) 243-248.